Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15,528 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early lumen loss after repeat coronary intervention for in-stent restenosis.
Malhotra S, Sweeny J, Anderson J, Lynch T, Massullo V, Jani S, Schatz RA, Tripuraneni P, Teirstein PS. Malhotra S, et al. Among authors: anderson j. Catheter Cardiovasc Interv. 2001 Jan;52(1):35-8. doi: 10.1002/1522-726x(200101)52:1<35::aid-ccd1008>3.0.co;2-r. Catheter Cardiovasc Interv. 2001. PMID: 11146518 Clinical Trial.
A Pharmacist Medication Titration Program for Patients with Cardiac Sarcoidosis and Systolic Heart Failure: A Retrospective Cohort Study.
Sykora D, Olson N, Churchill R, Kim BM, Bratcher M, Elwazir M, Young K, Ryan S, Brodin M, Anderson J, Saunders J, Ezzeddine OA, Bois J, Giudicessi J, Cooper L, Rosenbaum A. Sykora D, et al. Among authors: anderson j. J Am Heart Assoc. 2024 Nov 18:e038965. doi: 10.1161/JAHA.124.038965. Online ahead of print. J Am Heart Assoc. 2024. PMID: 39556701
Inclusivity in fNIRS Studies: Quantifying the Impact of Hair and Skin Characteristics on Signal Quality with Practical Recommendations for Improvement.
Yücel MA, Anderson JE, Rogers D, Hajirahimi P, Farzam P, Gao Y, Kaplan RI, Braun EJ, Muqadam N, Duwadi S, Carlton L, Beeler D, Butler L, Carpenter E, Girnis J, Wilson J, Tripathi V, Zhang Y, Sorger B, von Lühmann A, Somers D, Cronin-Golomb A, Kiran S, Ellis TD, Boas DA. Yücel MA, et al. Among authors: anderson je. bioRxiv [Preprint]. 2024 Oct 28:2024.10.28.620644. doi: 10.1101/2024.10.28.620644. bioRxiv. 2024. PMID: 39554177 Free PMC article. Preprint.
Pembrolizumab 400 mg every 6 weeks as first-line therapy for advanced melanoma (KEYNOTE-555): Results from cohort B of an open-label, phase 1 study.
Cohen G, Rapoport B, Chan SW, Ruff P, Arance A, Mujika Eizmendi K, Houghton B, Brown MP, Zielinski RM, Muñoz Couselo E, Lyle M, Anderson JR, Jain L, de Alwis D, Lala M, Akala O, Chartash E, Jacobs C. Cohen G, et al. Among authors: anderson jr. PLoS One. 2024 Nov 12;19(11):e0309778. doi: 10.1371/journal.pone.0309778. eCollection 2024. PLoS One. 2024. PMID: 39531423 Free PMC article. Clinical Trial.
15,528 results
You have reached the last available page of results. Please see the User Guide for more information.